| Type | Period | Ended | Filed | |
|---|---|---|---|---|
| 10-K | FY 2025 | 12/31/25 | 2/17/26 | → |
| 10-Q | Q3 2025 | 9/30/25 | 11/3/25 | → |
| 10-Q | Q2 2025 | 6/30/25 | 8/1/25 | → |
| 10-Q | Q1 2025 | 3/31/25 | 5/1/25 | → |
| 10-K | FY 2024 | 12/31/24 | 2/18/25 | → |
| 10-Q | Q3 2024 | 9/30/24 | 11/1/24 | → |
| ↓ | ||||
| Filed | Period | |
|---|---|---|
| 2/4/26 | Q1 FY2026 | → |
| 10/22/25 | Q3 FY2025 | → |
| 7/23/25 | Q2 FY2025 | → |
| 4/23/25 | Q1 FY2025 | → |
| 2/5/25 | Q1 FY2025 | → |
| 10/23/24 | Q3 FY2024 | → |
| ↓ | ||
| Filed | Type | Description | |
|---|---|---|---|
| 2/26/26 | Agreement | Entry into a Material Definitive Agreement | → |
| 2/23/26 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 2/5/26 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 1/15/26 | Agreement | Entry into a Material Definitive Agreement | → |
| 1/15/26 | Reg FD | Regulation FD Disclosure | → |
| 11/19/25 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/27/26 | S-4 | S-4 | → |
| 3/19/25 | ARS | ARS | → |
| 2/24/25 | 424B2 | 424B2 | → |
| 2/21/25 | FWP | FWP | → |
| 2/21/25 | 424B5 | 424B5 | → |
| 2/18/25 | S-3ASR | S-3ASR | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/6/26 | PRE 14A | PRE 14A | → |
| 3/19/25 | DEFA14A | DEFA14A | → |
| 3/19/25 | DEF 14A | DEF 14A | → |
| 4/29/24 | DEFA14A | DEFA14A | → |
| 3/20/24 | DEFA14A | DEFA14A | → |
| 3/20/24 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/4/26 | 4 | 4 | → |
| 3/4/26 | 4 | 4 | → |
| 3/4/26 | 4 | 4 | → |
| 3/4/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 2/27/26 | 4 | 4 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/3/26 | 425 | 425 | → |
| 2/4/26 | 425 | FORM 425 | → |
| 2/2/26 | 144 | 144 | → |
| 1/20/26 | 425 | FORM 425 | → |
| 1/20/26 | 425 | FORM 425 | → |
| 1/15/26 | 425 | FOR 425 | → |
| ↓ | |||
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.